チャン・ガン記念病院はDC-CIK免疫療法とCAR-T細胞療法によるがん治療を進めてきました. Chang Gung Memorial Hospital has advanced cancer treatment through DC-CIK immunotherapy and CAR-T cell therapy.

台湾のチャン・ガン記念病院は2018年以来,がんの細胞治療を先駆けており,免疫細胞と再生医療の臨床試験のための最先端の研究室を設立しました. Chang Gung Memorial Hospital in Taiwan has pioneered cellular therapy for cancer since 2018, establishing a state-of-the-art lab for clinical trials in immune cells and regenerative medicine. 注目すべき進歩には,肝がんにおける70~80%の疾患制御率を示したDC-CIK免疫療法と,急性リンパ性白血病と拡散性大B細胞リンパ腫に有効なCAR-T細胞療法が含まれています. Notable advancements include DC-CIK immunotherapy, which has shown a 70-80% disease control rate in liver cancer, and CAR-T cell therapy, effective for acute lymphoblastic leukemia and diffuse large B-cell lymphoma. これらの革新は 癌治療の効果と 患者の生活の質を向上させ 癌治療の形を変えてくれます These innovations are reshaping cancer treatment, improving effectiveness and patient quality of life.